<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vtio</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник трансплантологии и искусственных органов</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Transplantology and Artificial Organs</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-1191</issn><publisher><publisher-name>Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15825/1995-1191-2022-4-7-14</article-id><article-id custom-type="elpub" pub-id-type="custom">vtio-1573</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Клиническая трансплантология</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Clinical Transplantology</subject></subj-group></article-categories><title-group><article-title>Факторы риска при трансплантации печени от посмертного донора: опыт одного центра</article-title><trans-title-group xml:lang="en"><trans-title>Risk factors in deceased donor liver transplantation: a single centre experience</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зубенко</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Zubenko</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зубенко Степан Игоревич</p><p>123182, Москва, ул. Щукинская, д. 1</p><p>Тел. (495) 190-35-62</p></bio><bio xml:lang="en"><p>Stepan Zubenko</p><p>1, Shchukinskaya str., Moscow, 123182, Russian Federation</p><p>Phone: (495) 190-35-62</p></bio><email xlink:type="simple">zubenko_transpl@yahoo.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Монахов</surname><given-names>А. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Monakhov</surname><given-names>A. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Болдырев</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Boldyrev</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Салимов</surname><given-names>В. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Salimov</surname><given-names>V. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смолянинова</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Smolianinova</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Готье</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gautier</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Shumakov National Medical Research Center of Transplantology and Artificial Organs</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России; ФГАОУ ВО Первый Московский государственный медицинский университет имени И.М. Сеченова Минздрава России (Сеченовский университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Shumakov National Medical Research Center of Transplantology and Artificial Organs; Sechenov University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>04</day><month>10</month><year>2022</year></pub-date><volume>24</volume><issue>4</issue><fpage>7</fpage><lpage>14</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Зубенко С.И., Монахов А.Р., Болдырев М.А., Салимов В.Р., Смолянинова А.Д., Готье С.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Зубенко С.И., Монахов А.Р., Болдырев М.А., Салимов В.Р., Смолянинова А.Д., Готье С.В.</copyright-holder><copyright-holder xml:lang="en">Zubenko S.I., Monakhov A.R., Boldyrev M.A., Salimov V.R., Smolianinova A.D., Gautier S.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.transpl.ru/vtio/article/view/1573">https://journal.transpl.ru/vtio/article/view/1573</self-uri><abstract><p>Трансплантация печени от донора со смертью головного мозга – вмешательство высокого риска, на результаты которого влияет большое количество модифицируемых и немодифицируемых факторов. Цель: провести анализ собственного опыта и выявить предоперационные и периоперационные прогностические факторы риска неблагоприятного исхода при трансплантации печени. Материалы и методы. В исследование включены трансплантации печени (n = 301), выполненные за период с января 2016-го по декабрь 2021 г. Для анализа использованы характеристики доноров и реципиентов, интраоперационные данные, периоперационные характеристики, включая данные лабораторных тестов, а также характер и частоту осложнений. Результаты. Выживаемость реципиентов составила: 91,8; 85,1 и 77,9% на сроке 1, 3 и 5 лет после операции; выживаемость трансплантатов – 90,4; 83,7 и 76,7% соответственно. Наиболее значимыми предикторами неблагоприятного исхода трансплантации печени со стороны реципиента стали наличие билиарных стентов (HR 7,203, p &lt; 0,01), острая декомпенсация течения цирроза печени (HR 2,52, p = 0,02); в послеоперационном периоде – нехирургические инфекционные осложнения (HR 4,592, p &lt; 0,01) и количество повторных операций (HR 4,063, p &lt; 0,01). Уровень креатинина донора (HR 1,004, p = 0,01 – однофакторный анализ; HR 1,004, p = 0,016 – многофакторный анализ) является единственным достоверным прогностически негативным фактором. Выводы. Выполнение трансплантации печени с учетом установленных факторов риска позволит улучшить результаты операций, а также персонализировать терапию для каждого пациента.</p></abstract><trans-abstract xml:lang="en"><p>Deceased brain-dead donor liver transplantation (LT) is a high-risk intervention. The outcome depends on a large number of modifiable and non-modifiable factors. Objective: to analyze our own experience and identify preoperative and perioperative prognostic factors for poor outcomes in LT. Materials and methods. The study included 301 liver transplants performed between January 2016 and December 2021. Donor and recipient characteristics, intraoperative data, perioperative characteristics including laboratory test data, and the nature and frequency of complications were used for the analysis. Results. The 1-, 3- and 5-year recipient survival rates were 91.8%, 85.1%, and 77.9%, respectively; graft survival rates were 90.4%, 83.7%, and 76.7%, respectively. The most significant predictors of poor outcome of LT on the recipient side were biliary stents (HR 7.203, p &lt; 0.01), acutely decompensated cirrhosis (HR 2.52, p = 0.02); in the postoperative period, non-surgical infectious complications (HR 4.592, p &lt; 0.01) and number of reoperations (HR 4.063, p &lt; 0.01). Donor creatinine level (HR 1.004, p = 0.01, one factor analysis; HR 1.004, p = 0.016, multivariate analysis) was the only reliable prognostic negative factor. Conclusion. LT taking into account established risk factors will improve surgery outcomes and help personalize the therapy for each patient.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>трансплантация печени</kwd><kwd>посмертное донорство</kwd><kwd>факторы риска</kwd></kwd-group><kwd-group xml:lang="en"><kwd>liver transplantation</kwd><kwd>deceased donor</kwd><kwd>expanded criteria donor</kwd><kwd>risk factors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Busuttil RW, Klintmalm G. Transplantation of the Liver 3rd Edition. Elsevier Health Sciences. 2014: 1538.</mixed-citation><mixed-citation xml:lang="en">Busuttil RW, Klintmalm G. Transplantation of the Liver 3rd Edition. Elsevier Health Sciences. 2014: 1538.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Montenovo M, Rahnemai-Azar A, Reyes J, Perkins J. Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant. Exp Clin Transplant. 2018 Apr; 16 (2): 166–171. doi: 10.6002/ ect.2016.0277. Epub 2017 Jun 16. PMID: 286216359.</mixed-citation><mixed-citation xml:lang="en">Montenovo M, Rahnemai-Azar A, Reyes J, Perkins J. Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant. Exp Clin Transplant. 2018 Apr; 16 (2): 166–171. doi: 10.6002/ ect.2016.0277. Epub 2017 Jun 16. PMID: 286216359.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ebadi M, Montano-Loza AJ. Sarcopenia and Frailty in the Prognosis of Patients on the Liver Transplant Waiting List. Liver Transpl. 2019 Jan; 25 (1): 7–9. doi: 10.1002/lt.25386. PMID: 30472786.</mixed-citation><mixed-citation xml:lang="en">Ebadi M, Montano-Loza AJ. Sarcopenia and Frailty in the Prognosis of Patients on the Liver Transplant Waiting List. Liver Transpl. 2019 Jan; 25 (1): 7–9. doi: 10.1002/lt.25386. PMID: 30472786.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Qi X, Dai J, Jia J, Ren W, Yang M, Li H et al. Association between portal vein thrombosis and survival of liver transplant recipients: a systematic review and metaanalysis of observational studies. J Gastrointestin Liver Dis. 2015 Mar; 24 (1): 51–59, 4 p following 59. doi: 10.15403/jgld.2014.1121.qix. PMID: 25822434.</mixed-citation><mixed-citation xml:lang="en">Qi X, Dai J, Jia J, Ren W, Yang M, Li H et al. Association between portal vein thrombosis and survival of liver transplant recipients: a systematic review and metaanalysis of observational studies. J Gastrointestin Liver Dis. 2015 Mar; 24 (1): 51–59, 4 p following 59. doi: 10.15403/jgld.2014.1121.qix. PMID: 25822434.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Поршенников ИА, Соколов АВ, Щекина ЕЕ, Чубуков АЮ, Третьякова ТА, Останина ИБ и др. Трансплантация печени при метастатическом колоректальном раке (клиническое наблюдение). Анналы хирургической гепатологии. 2018; 23 (4): 54–67.</mixed-citation><mixed-citation xml:lang="en">Porshennikov IA, Sokolov AV, Shchekina EE, Chubukov AYu, Tret’yakova TA, Ostanina IB i dr. Transplantatsiya pecheni pri metastaticheskom kolorektal’nom rake (klinicheskoe nablyudenie). Annaly khirurgicheskoy gepatologii. 2018; 23 (4): 54–67. https://doi.org/10.16931/1995-5464.2018454-67.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Orman ES, Barritt AS, Wheeler SB, Hayashi PH. Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death. Liver Transpl. 2013; 19: 59–68.</mixed-citation><mixed-citation xml:lang="en">Orman ES, Barritt AS, Wheeler SB, Hayashi PH. Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death. Liver Transpl. 2013; 19: 59–68.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Готье СВ, Корнилов МН, Милосердов ИА и др. Трансплантация печени от доноров старше 60 лет. Вестник трансплантологии и искусственных органов. 2018; 20 (1): 6–12.</mixed-citation><mixed-citation xml:lang="en">Gautier SV, Kornilov MN, Miloserdov IA i dr. Transplantatsiya pecheni ot donorov starshe 60 let. Vestnik transplantologii i iskusstvennykh organov. 2018; 20 (1): 6–12.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Stine JG, Argo CK, Pelletier SJ, Maluf DG, Northup PG. Liver transplant recipients with portal vein thrombosis receiving an organ from a high-risk donor are at an increased risk for graft loss due to hepatic artery thrombosis. Transpl Int. 2016 Dec; 29 (12): 1286–1295. doi: 10.1111/tri.12855. Epub 2016 Oct 6. PMID: 27714853; PMCID: PMC5154764.</mixed-citation><mixed-citation xml:lang="en">Stine JG, Argo CK, Pelletier SJ, Maluf DG, Northup PG. Liver transplant recipients with portal vein thrombosis receiving an organ from a high-risk donor are at an increased risk for graft loss due to hepatic artery thrombosis. Transpl Int. 2016 Dec; 29 (12): 1286–1295. doi: 10.1111/tri.12855. Epub 2016 Oct 6. PMID: 27714853; PMCID: PMC5154764.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Nacif LS, Zanini LY, Pinheiro RS, Waisberg DR, RochaSantos V, Andraus W et al. Portal vein surgical treatment on non-tumoral portal vein thrombosis in liver transplantation: Systematic Review and Meta-Analysis. Clinics (Sao Paulo). 2021 Jan 22; 76: e2184. doi: 10.6061/clinics/2021/e2184. PMID: 33503185; PMCID: PMC7811829.</mixed-citation><mixed-citation xml:lang="en">Nacif LS, Zanini LY, Pinheiro RS, Waisberg DR, RochaSantos V, Andraus W et al. Portal vein surgical treatment on non-tumoral portal vein thrombosis in liver transplantation: Systematic Review and Meta-Analysis. Clinics (Sao Paulo). 2021 Jan 22; 76: e2184. doi: 10.6061/clinics/2021/e2184. PMID: 33503185; PMCID: PMC7811829.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Stine JG, Northup PG. Management of Non-tumoral Portal Vein Thrombosis in Patients with Cirrhosis. Dig Dis Sci. 2019 Mar; 64 (3): 619–626. doi: 10.1007/s10620-018-5427-3. PMID: 30560339.</mixed-citation><mixed-citation xml:lang="en">Stine JG, Northup PG. Management of Non-tumoral Portal Vein Thrombosis in Patients with Cirrhosis. Dig Dis Sci. 2019 Mar; 64 (3): 619–626. doi: 10.1007/s10620-018-5427-3. PMID: 30560339.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Погребниченко ИВ. Эффективное использование печени мультиорганного донора для трансплантации: дис. … канд. мед. наук. М., 2014. 143.</mixed-citation><mixed-citation xml:lang="en">Pogrebnichenko IV. Jeffektivnoe ispol’zovanie pecheni mul’tiorgannogo donora dlja transplantacii [Dissertation]. M.: 2014. 143.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Латыпов РА. Сплит-трансплантация печени: дис. … канд. мед. наук: 14.01.24. М., 2019. 125. Latypov RA. Split-transplantatsiya pecheni: dis. … kand. med. nauk: 14.01.24. M., 2019. 125.</mixed-citation><mixed-citation xml:lang="en">Latypov RA. Split-transplantatsiya pecheni: dis. … kand. med. nauk: 14.01.24. M., 2019. 125.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Восканов МА. Интервенционные методы коррекции сосудистых осложнений и билиодигестивных стриктур после трансплантации печени у детей: дис. … канд. мед. наук: 14.01.24. М., 2020. 109.</mixed-citation><mixed-citation xml:lang="en">Voskanov MA. Interventsionnye metody korrektsii sosudistykh oslozhneniy i biliodigestivnykh striktur posle transplantatsii pecheni u detey: dis. … kand. med. nauk: 14.01.24. M., 2020. 109.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Готье СВ, Попцов ВН, Корнилов МН и др. Методика кавальной реконструкции при трансплантации печени от посмертного донора – выбор хирурга или анестезиолога. Вестник трансплантологии и искусственных органов. 2018; 20 (S1): 62.</mixed-citation><mixed-citation xml:lang="en">Gautier SV, Poptsov VN, Kornilov MN i dr. Metodika kaval’noy rekonstruktsii pri transplantatsii pecheni ot posmertnogo donora – vybor khirurga ili anesteziologa. Vestnik transplantologii i iskusstvennykh organov. 2018; 20 (S1): 62.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Трансплантация печени: национальные клинические рекомендации / Общероссийская общественная организация трансплантологов «Российское трансплантологическое общество». М., 2016. 61.</mixed-citation><mixed-citation xml:lang="en">Transplantatsiya pecheni: natsional’nye klinicheskie rekomendatsii / Obshcherossiyskaya obshchestvennaya organizatsiya transplantologov «Rossiyskoe transplantologicheskoe obshchestvo». M., 2016. 61.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006 Apr; 6 (4): 783–790. doi: 10.1111/j.1600-6143.2006.01242.x. Erratum in: Am J Transplant. 2018 Dec; 18 (12): 3085. PMID: 16539636, 165.</mixed-citation><mixed-citation xml:lang="en">Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006 Apr; 6 (4): 783–790. doi: 10.1111/j.1600-6143.2006.01242.x. Erratum in: Am J Transplant. 2018 Dec; 18 (12): 3085. PMID: 16539636, 165.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Serrano MT, Sabroso S, Esteban LM, Berenguer M, Fondevila C, Lorente S et al. Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort. Transpl Int. 2022 May 9; 35: 10263. doi: 10.3389/ti.2022.10263. PMID: 35615539; PMCID: PMC9124758.</mixed-citation><mixed-citation xml:lang="en">Serrano MT, Sabroso S, Esteban LM, Berenguer M, Fondevila C, Lorente S et al. Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort. Transpl Int. 2022 May 9; 35: 10263. doi: 10.3389/ti.2022.10263. PMID: 35615539; PMCID: PMC9124758.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Isik O, Kaya E, Sarkut P, Dundar HZ. Factors Affecting Surgical Site Infection Rates in Hepatobiliary Surgery. Surg Infect (Larchmt). 2015 Jun; 16 (3): 281–286. doi: 10.1089/sur.2013.195. Epub 2015 Apr 1. PMID: 25830815.</mixed-citation><mixed-citation xml:lang="en">Isik O, Kaya E, Sarkut P, Dundar HZ. Factors Affecting Surgical Site Infection Rates in Hepatobiliary Surgery. Surg Infect (Larchmt). 2015 Jun; 16 (3): 281–286. doi: 10.1089/sur.2013.195. Epub 2015 Apr 1. PMID: 25830815.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Vaishnavi C, Samanta J, Kochhar R. Characterization of biofilms in biliary stents and potential factors involved in occlusion. World J Gastroenterol. 2018 Jan 7; 24 (1): 112–123. doi: 10.3748/wjg.v24.i1.112. PMID: 29358888; PMCID: PMC5757116.</mixed-citation><mixed-citation xml:lang="en">Vaishnavi C, Samanta J, Kochhar R. Characterization of biofilms in biliary stents and potential factors involved in occlusion. World J Gastroenterol. 2018 Jan 7; 24 (1): 112–123. doi: 10.3748/wjg.v24.i1.112. PMID: 29358888; PMCID: PMC5757116.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Kim YJ, Yoon JH, Kim SI, Choi HJ, Choi JY, Yoon SK et al. Impact of Pretransplant Infections on Clinical Course in Liver Transplant Recipients. Transplant Proc. 2018 May; 50 (4): 1153–1156. doi: 10.1016/j.transproceed.2018.01.036. PMID: 29731084.</mixed-citation><mixed-citation xml:lang="en">Kim YJ, Yoon JH, Kim SI, Choi HJ, Choi JY, Yoon SK et al. Impact of Pretransplant Infections on Clinical Course in Liver Transplant Recipients. Transplant Proc. 2018 May; 50 (4): 1153–1156. doi: 10.1016/j.transproceed.2018.01.036. PMID: 29731084.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S et al. APASL ACLF Research Consortium (AARC) for APASL ACLF working Party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019 Jul; 13 (4): 353–390. doi: 10.1007/s12072-019-09946-3. Epub 2019 Jun 6. Erratum in: Hepatol Int. 2019 Nov; 13 (6): 826–828. PMID: 31172417; PMCID: PMC6728300.</mixed-citation><mixed-citation xml:lang="en">Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S et al. APASL ACLF Research Consortium (AARC) for APASL ACLF working Party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019 Jul; 13 (4): 353–390. doi: 10.1007/s12072-019-09946-3. Epub 2019 Jun 6. Erratum in: Hepatol Int. 2019 Nov; 13 (6): 826–828. PMID: 31172417; PMCID: PMC6728300.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Torterolli F, Watanabe RK, Tabushi FI, Peixoto IL, Nassif PAN, Tefilli NL et al. Bar, soft and dri post-hepatic transplantation: what is the best for survival analysis? Arq Bras Cir Dig. 2021 Jun 11; 34 (1): e1576. doi: 10.1590/0102-672020210001e1576. PMID: 34133523; PMCID: PMC8195467.</mixed-citation><mixed-citation xml:lang="en">Torterolli F, Watanabe RK, Tabushi FI, Peixoto IL, Nassif PAN, Tefilli NL et al. Bar, soft and dri post-hepatic transplantation: what is the best for survival analysis? Arq Bras Cir Dig. 2021 Jun 11; 34 (1): e1576. doi: 10.1590/0102-672020210001e1576. PMID: 34133523; PMCID: PMC8195467.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Rogers ME, Delman A, Campbell K, Miethke A, Tiao G, Mullapudi B, Bondoc A. Children undergoing early liver re-transplantation for primary non-function have improved survival. Pediatr Transplant. 2022 Jun 25: e14347. doi: 10.1111/petr.14347. Epub ahead of print. PMID: 35751646.</mixed-citation><mixed-citation xml:lang="en">Rogers ME, Delman A, Campbell K, Miethke A, Tiao G, Mullapudi B, Bondoc A. Children undergoing early liver re-transplantation for primary non-function have improved survival. Pediatr Transplant. 2022 Jun 25: e14347. doi: 10.1111/petr.14347. Epub ahead of print. PMID: 35751646.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Boecker J, Czigany Z, Bednarsch J, Amygdalos I, Meister F, Santana DAM et al. Potential value and limitations of different clinical scoring systems in the assessment of short- and long-term outcome following orthotopic liver transplantation. PLoS One. 2019 Mar 21; 14 (3): e0214221. doi: 10.1371/journal.pone.0214221. PMID: 30897167; PMCID: PMC6428268.</mixed-citation><mixed-citation xml:lang="en">Boecker J, Czigany Z, Bednarsch J, Amygdalos I, Meister F, Santana DAM et al. Potential value and limitations of different clinical scoring systems in the assessment of short- and long-term outcome following orthotopic liver transplantation. PLoS One. 2019 Mar 21; 14 (3): e0214221. doi: 10.1371/journal.pone.0214221. PMID: 30897167; PMCID: PMC6428268.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Rauchfuss F, Zidan A, Scheuerlein H, Dittmar Y, Bauschke A, Settmacher U. Waiting time, not donor-risk-index, is a major determinant for beneficial outcome after liver transplantation in high-MELD patients. Ann Transplant. 2013 May 28; 18: 243–247. doi: 10.12659/AOT.883924. PMID: 23792527.</mixed-citation><mixed-citation xml:lang="en">Rauchfuss F, Zidan A, Scheuerlein H, Dittmar Y, Bauschke A, Settmacher U. Waiting time, not donor-risk-index, is a major determinant for beneficial outcome after liver transplantation in high-MELD patients. Ann Transplant. 2013 May 28; 18: 243–247. doi: 10.12659/AOT.883924. PMID: 23792527.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Teofili L, Valentini CG, Aceto P, Bartolo M, Sollazzi L, Agnes S et al. High intraoperative blood product requirements in liver transplantation: risk factors and impact on the outcome. Eur Rev Med Pharmacol Sci. 2022 Jan; 26 (1): 64–75. doi: 10.26355/eurrev_202201_27749. PMID: 35049021.</mixed-citation><mixed-citation xml:lang="en">Teofili L, Valentini CG, Aceto P, Bartolo M, Sollazzi L, Agnes S et al. High intraoperative blood product requirements in liver transplantation: risk factors and impact on the outcome. Eur Rev Med Pharmacol Sci. 2022 Jan; 26 (1): 64–75. doi: 10.26355/eurrev_202201_27749. PMID: 35049021.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Rostved AA, Lundgren JD, Hillingsø J, Peters L, Mocroft A, Rasmussen A. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year. Scand J Gastroenterol. 2016 Nov; 51 (11): 1360–1366. doi: 10.1080/00365521.2016.1196497. Epub 2016 Jun 20. PMID: 27319374.</mixed-citation><mixed-citation xml:lang="en">Rostved AA, Lundgren JD, Hillingsø J, Peters L, Mocroft A, Rasmussen A. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year. Scand J Gastroenterol. 2016 Nov; 51 (11): 1360–1366. doi: 10.1080/00365521.2016.1196497. Epub 2016 Jun 20. PMID: 27319374.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">OkamuraY,YagiS,SatoT,HataK,OgawaE,YoshizawaA et al. Coexistence of Bilirubin ≥10 mg/dL and Prothrombin Time-International Normalized Ratio ≥1.6 on Day 7: A Strong Predictor of Early Graft Loss After Living Donor Liver Transplantation. Transplantation. 2018 Mar; 102 (3): 440–447. doi: 10.1097/TP.0000000000001959. PMID: 28968350.</mixed-citation><mixed-citation xml:lang="en">OkamuraY,YagiS,SatoT,HataK,OgawaE,YoshizawaA et al. Coexistence of Bilirubin ≥10 mg/dL and Prothrombin Time-International Normalized Ratio ≥1.6 on Day 7: A Strong Predictor of Early Graft Loss After Living Donor Liver Transplantation. Transplantation. 2018 Mar; 102 (3): 440–447. doi: 10.1097/TP.0000000000001959. PMID: 28968350.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Chen RX, Wu ZQ, Li ZY, Wang HZ, Ji JF. Prognostic predictors in patients with sepsis after gastrointestinal tumor surgery: A retrospective study. World J Gastrointest Surg. 2021 Mar 27; 13 (3): 256–266. doi: 10.4240/wjgs. v13.i3.256. PMID: 33796214; PMCID: PMC7992996.</mixed-citation><mixed-citation xml:lang="en">Chen RX, Wu ZQ, Li ZY, Wang HZ, Ji JF. Prognostic predictors in patients with sepsis after gastrointestinal tumor surgery: A retrospective study. World J Gastrointest Surg. 2021 Mar 27; 13 (3): 256–266. doi: 10.4240/wjgs. v13.i3.256. PMID: 33796214; PMCID: PMC7992996.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Liu J, Bai C, Li B, Shan A, Shi F, Yao C et al. Mortality prediction using a novel combination of biomarkers in the first day of sepsis in intensive care units. Sci Rep. 2021 Jan 14; 11 (1): 1275. doi: 10.1038/s41598-020-79843-5. PMID: 33446739; PMCID: PMC7809407.</mixed-citation><mixed-citation xml:lang="en">Liu J, Bai C, Li B, Shan A, Shi F, Yao C et al. Mortality prediction using a novel combination of biomarkers in the first day of sepsis in intensive care units. Sci Rep. 2021 Jan 14; 11 (1): 1275. doi: 10.1038/s41598-020-79843-5. PMID: 33446739; PMCID: PMC7809407.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Ben-Ari Z, Weiss-Schmilovitz H, Sulkes J, Brown M, BarNathan N, Shaharabani E et al. Serum cholestasis markers as predictors of early outcome after liver transplantation. Clin Transplant. 2004 Apr; 18 (2): 130–136. doi: 10.1046/j.1399-0012.2003.00135.x. PMID: 15016125.</mixed-citation><mixed-citation xml:lang="en">Ben-Ari Z, Weiss-Schmilovitz H, Sulkes J, Brown M, BarNathan N, Shaharabani E et al. Serum cholestasis markers as predictors of early outcome after liver transplantation. Clin Transplant. 2004 Apr; 18 (2): 130–136. doi: 10.1046/j.1399-0012.2003.00135.x. PMID: 15016125.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
